Selenis launches recycle-ready Selcare CE 500 for healthcare

NEWS RELEASE: Selenis launch of Selcare CE 500 delivers high performance and RIC1 waste stream compatibility for sustainable Healthcare Packaging.

[Photo courtesy of Selenis]

Portugal — Selenis, a leading provider for specialty Copolyester solutions, is proud to announce the launch of Selcare CE 500 through its dedicated healthcare brand, Selcare. This breakthrough product is engineered as recycle-ready material that meets the requirements for RIC1 identification, while upholding the highest standards of performance within this PET waste stream.

Selcare CE 500 joins the established innovative range of Selcare medical grade, where sustainability is a strong focus. Selcare CE 500 is a low glycol modified polymer resin engineered specifically for film extrusion in healthcare packaging. Manufactured to the highest quality standards, it is designed to meet the stringent demands of the regulated healthcare industry.

“Our innovative batch production technology has enabled Selcare to develop a low glycol modified polyester that delivers exceptional performance, designed to be recycled in the RIC 1 stream. This tailor-made glycol modification provides improved processability, superior sealing, and enhanced impact resistance compared to existing modified APETs. By offering this at a price point between standard APET and PETG healthcare grades, Selcare CE 500 is a truly cost-competitive and sustainable solution that facilitates closing loops in healthcare packaging.” – said Eduardo Santos, Global Head of Strategy for Selcare.

The Selcare CE 500 resin delivers exceptional clarity, a neutral color, and a high-gloss finish, ensuring excellent visual performance and product visibility. Furthermore, it comes with comprehensive regulatory declarations, including ISO 10993, USP Class VI, USP <661.1>, and ICH Q3D. Importantly, Selcare CE 500 is free of intentionally added BPA, aligning with the industry’s safety expectations and regulatory compliance. Change control and notification is included as standard.

In partnership with a leading manufacturer of masterbatch concentrates, all Selcare grades can be customised for color and performance to meet individual customer specifications while adhering to the same healthcare regulatory requirements.

As healthcare customers increasingly demand sustainable, compliant, and future-proof materials, many conventional packaging solutions are falling short. Selenis’ Selcare brand offers a robust and transparent value proposition built to support the unique needs of the healthcare industry, today and tomorrow.

The Selcare model ensures security of supply through manufacturing at multiple sites, a well- defined business continuity plan with back-up supply options, and full technical support and advice across development and production stages. Customers can also expect dedicated assistance for MDR (Medical Device Regulation) compliance, along with complete formulation disclosure and notification of change protocols, giving them confidence and control.

The Selcare CE 500 product features in a webinar series on Sustainability in Polyesters for Healthcare Applications on the 5th Nov 2025, brought to you by Selenis (Selcare resins) in collaboration with Resinex.

Click here to register

About Selcare

Selcare is a brand of Selenis, producer of specialty resins for a diverse range of medical applications. Selenis is a member of the IMG Group, present in the polymers market since 1959. Selenis aspires to improve patient safety with solutions specifically developed for the medical value chain.

Our Selcare brand offers high performing medical grade plastics and a wide range of supporting services.

Selenis is a producer of specialty polyesters for a wide range of applications. For medical applications we offer dedicated medical grade resins. We do not promote or authorise the use of non-medical grades in medical applications.

It is the responsibility of the medical device manufacturer to determine the suitability of the chosen Selenis resin used in its final product in order to ensure safety and compliance with the relevant laws and regulations. The medical device manufacturer is also responsible for the biological evaluation of the finished medical device.

Selenis resin shall not be used for:

• implant devices as defined by United States FDA, by the International Standards Organisation (ISO) or by EU Medical Device Regulation 2017/745;
• any applications in continuous contact with bodily fluids for longer than 30 days;
• any cardiac prosthetic device application;
• any critical component in a permanently (longer than 30 days) implanted medical device that supports or sustains human life.

The suitability of a Selenis resin depends on the conditions in the end-use environment including temperature, part design, sterilisation method, residual stresses, chemical compatibility, and external loads. lt is the responsibility of the medical device manufacturer to evaluate its final product under actual end-use requirements and to adequately advise and warn purchasers and users thereof.

About Selenis

Selenis is a global premium supplier of specialty copolyesters for diverse markets and applications. Selenis has developed engineered resins that fit high demanding applications to manufacture products that are used in everyday life. Being part of a group who has been in the polymers industry for over sixty years; Selenis counts on a wealth of expertise and know-how. We share our global experience to provide customers with products that are one step ahead. Selenis is constantly on the search for innovation in materials and industrial technology in order to deliver ground-breaking specialty polyester solutions that focus on a circular economy. We believe that through dialogue with our customers we can develop new tailor-made formulations motivated by their requirements as well as market trends. At Selenis we are centered on innovation through more environmentally responsible resins. Our R&D experts and Sustainability Committee continuously seek more sustainable and recyclable solutions. Our philosophy is based on driving technology and innovation towards a sustainable portfolio. To discover more, please visit our website at www.selenis.com

The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.